Cystatin SN (CST1) as a Novel Salivary Biomarker of Periodontitis
Abstract
:1. Introduction
2. Results
2.1. Clinical Findings
2.2. Salivary Proteomic Signature
2.3. Validation of Selected Protein by Western Blot Analysis
2.4. Correlation Analysis between CST1 Expression and Clinical Variables
2.5. Cluster Analysis
3. Discussion
4. Materials and Methods
4.1. Study Design and Population
- (i)
- Periodontally Healthy Controls (H) group: no history of periodontitis, no loss of interdental clinical attachment level (CAL), no radiographic evidence of bone loss, and full-mouth bleeding score (FMBS) < 10%;
- (ii)
- Severe Periodontitis (P) group: diagnosis of stage III or stage IV generalized periodontitis, CAL loss ≥ 5 mm, probing pocket depth (PPD) ≥ 6 mm, radiographic evidence of bone loss extending to the middle or apical third of the root, ≥30% of teeth at the stage-defining severity level, no periodontal treatment within 12 months before enrolment;
- (iii)
- Treated Periodontitis (T) group: reduced but stable periodontium after active periodontal treatment for stage III or stage IV generalized periodontitis, no sites with PPD > 4 mm or PPD = 4 mm with BoP, and FMBS < 10%. Periodontal treatment was conducted according to the EFP S3 level clinical practice guideline for stage I–III periodontitis [41]). When needed, the multidisciplinary management of stage IV periodontitis was implemented according to EFP S3 level clinical practice guideline for stage IV periodontitis [52]. Following the completion of active periodontal therapy, patients were enrolled in a tailored supportive periodontal care program.
4.2. Periodontal Examination
4.3. Salivary Collection and Protein Sample Preparation
4.4. Two-Dimensional Gel Electrophoresis
4.5. Mass Spectrometry and Protein Identification
4.6. Western Blot
4.7. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Tonetti, M.S.; Greenwell, H.; Kornman, K.S. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J. Clin. Periodontol. 2018, 45 (Suppl. 20), S149–S161. [Google Scholar] [CrossRef] [PubMed]
- Tonetti, M.S.; Jepsen, S.; Jin, L.; Otomo-Corgel, J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. J. Clin. Periodontol. 2017, 44, 456–462. [Google Scholar] [CrossRef]
- Hajishengallis, G. Periodontitis: From microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 2015, 15, 30–44. [Google Scholar] [CrossRef]
- Romano, F.; Perotto, S.; Elamin Osamn-Mohamed, S.; Bernardi, S.; Giraudi, M.; Caropreso, P.; Mengozzi, G.; Baima, G.; Citterio, F.; Berta, G.N.; et al. Bidirectional association between metabolic control in type-2 diabetes mellitus and periodontitis inflammatory burden: A cross-sectional study in an Italiam population. J. Clin. Med. 2021, 10, 1787. [Google Scholar] [CrossRef]
- Baima, G.; Muwalla, M.; Testa, G.; Mazza, F.; Bebars, A.; Perotto, S.; Vernero, M.; Massano, A.; Romano, F.; Ribaldone, D.G.; et al. Periodontitis prevalence and severity in inflammatory bowel disease: A case–control study. J. Periodontol. 2023, 94, 313–322. [Google Scholar] [CrossRef]
- Kassebaum, N.J.; Bernabé, E.; Dahiya, M.; Bhandari, B.; Murray, C.J.; Marcenes, W. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. J. Dent. Res. 2014, 93, 1045–1053. [Google Scholar] [CrossRef] [PubMed]
- Chen, M.X.; Zhong, Y.J.; Dong, Q.Q.; Wong, H.M.; Wen, Y.F. Global, regional, and national burden of severe periodontitis, 1990–2019: An analysis of the Global Burden of Disease Study 2019. J. Periodontol. 2022, 93, 1445–1454. [Google Scholar] [CrossRef]
- Preshaw, P.M. Detection and diagnosis of periodontal conditions amenable to prevention. BMC Oral Health. 2015, 15 (Suppl. 1), 5. [Google Scholar] [CrossRef]
- Caton, J.G.; Armitage, G.; Berglundh, T.; Chapple, I.L.C.; Jepsen, S.; Kornman, K.; Mealey, B.L.; Papapanou, P.N.; Sanz, M.; Tonetti, M.S. A new classification scheme for periodontal and peri-implant diseases and conditions-Introduction and key changes from the 1999 classification. J. Cin. Periodontol. 2018, 45 (Suppl. 20), S1–S8. [Google Scholar] [CrossRef] [PubMed]
- Bostanci, N.; Bao, K.; Greenwood, D.; Silbereisen, A.; Belibasakis, G.N. Periodontal disease: From the lenses of light microscopy to the specs of proteomics and next-generation sequencing. Adv. Clin. Chem. 2019, 93, 263–290. [Google Scholar] [CrossRef]
- Lang, N.P.; Joss, A.; Orsanic, T.; Gusberti, F.A.; Siegrist, B.E. Bleeding on probing. A predictor for the progression of periodontal disease? J. Clin. Periodontol. 1996, 13, 590–596. [Google Scholar] [CrossRef]
- Arias-Bujanda, N.; Regueira-Iglesias, A.; Balsa-Castro, C.; Nibali, L.; Donos, N.; Tomás, I. Accuracy of single molecular biomarkers in saliva for the diagnosis of periodontitis: A systematic review and meta-analysis. J. Clin. Periodontol. 2020, 47, 2–18. [Google Scholar] [CrossRef]
- Kc, S.; Wang, X.Z.; Gallagher, J.E. Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review. J. Clin. Periodontol. 2020, 47, 289–308. [Google Scholar] [CrossRef] [PubMed]
- Baima, G.; Iaderosa, G.; Corana, M.; Romano, F.; Citterio, F.; Giacomino, A.; Berta, G.N.; Aimetti, M. Macro and trace elements signature of periodontitis in saliva: A systematic review with quality assessment of ionomics studies. J Periodontal. Res. 2021, 57, 30–40. [Google Scholar] [CrossRef]
- Romano, F.; Iaderosa, G.; Corana, M.; Perotto, S.; Baima, G.; Di Scipio, F.; Abbadessa, G.; Mariani, G.M.; Aimetti, M.; Berta, G.N. Comparing ionic profile of gingival crevicular fluid and saliva as distinctive signature of severe periodontitis. Biomed. 2022, 10, 687. [Google Scholar] [CrossRef]
- Grassl, N.; Kulak, N.A.; Pichler, G.; Geyer, P.E.; Jung, J.; Schubert, S.; Sinitcyn, P.; Cox, J.; Mann, M. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016, 8, 44. [Google Scholar] [CrossRef] [PubMed]
- Amado, F.; Lobo, M.J.C.; Domingues, P.; Duarte, J.A.; Vitorino, R. Salivary peptidomics. Expert Rev. Proteom. 2010, 7, 709–721. [Google Scholar] [CrossRef]
- Nguyen, T.; Sedghi, L.; Ganther, S.; Malone, E.; Kamarajan, P.; Kapila, Y.L. Host-microbe interactions: Profiles in the transcriptome, the proteome, and the metabolome. Periodontology 2000 2019, 82, 115–128. [Google Scholar] [CrossRef]
- Rizal, M.I.; Soeroso, Y.; Sulijaya, B.; Assiddiq, B.F.; Bachtiar, E.W.; Bachtiar, B.M. Proteomics approach for biomarkers and diagnosis of periodontitis: Systematic review. Heliyon 2020, 6, e04022. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Morikawa, K.; Mori, Y.; Zong, C.; Zhang, L.; Garner, E.; Huang, C.; Wu, W.; Chang, J.; Nagashima, D.; et al. Proteomic analysis of liver proteins of mice exposed to 1,2-dichloropropane. Arch. Toxicol. 2020, 94, 2691–2705. [Google Scholar] [CrossRef]
- Rafiullah, M.; Benabdelkamel, H.; Masood, A.; Ekhzaimy, A.A.; Musambil, M.; Joy, S.S.; Alfadda, A.A. Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment. Curr. Issues Mol. Biol. 2023, 45, 1407–1421. [Google Scholar] [CrossRef]
- Spielmann, N.; Wong, D.T. Saliva: Diagnostics and therapeutic perspectives. Oral Dis. 2011, 17, 345–354. [Google Scholar] [CrossRef] [PubMed]
- Wu, C.C.; Chu, H.W.; Hsu, C.W.; Chang, K.P.; Liu, H.P. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma. Proteomics 2015, 15, 3394–3404. [Google Scholar] [CrossRef]
- Bostanci, N.; Selevsek, N.; Wolski, W.; Grossmann, J.; Bao, K.; Wahlander, A.; Trachsel, C.; Schlapbach, R.; Öztürk, V.Ö.; Afacan, B.; et al. Targeted proteomics guided by label-free quantitative proteome analysis in saliva reveal transition signatures from health to periodontal disease. Mol. Cell. Proteomics 2018, 17, 1392–1409. [Google Scholar] [CrossRef]
- Korte, D.L.; Kinney, J. Personalized medicine: An update of salivary biomarkers for periodontal diseases. Periodontology 2000. 2016, 70, 26–37. [Google Scholar] [CrossRef]
- Morales-Bozo, I.; Urzua-Orellana, B.; Dominguez, P.; Aguilera, S.; Lopez-Solis, R. Patterns and variability in electrophoretic polypeptide profiles of human saliva in a healthy population. J. Physiol. Biochem. 2006, 62, 179–188. [Google Scholar] [CrossRef] [PubMed]
- Quintana, M.; Palicki, O.; Lucchi, G.; Ducoroy, P.; Chambon, C.; Salles, C.; Morzel, M. Inter-individual variability of protein patterns in saliva of healthy adults. J. Proteomics 2009, 72, 822–830. [Google Scholar] [CrossRef] [PubMed]
- Proctor, G.B. The physiology of salivary secretion. Periodontology 2000 2016, 70, 11–25. [Google Scholar] [CrossRef]
- Zhang, L.; Yu, S.; Yin, X.; Tu, M.; Cai, L.; Zhang, Y.; Yu, L.; Zhang, S.; Pan, X.; Huang, Y. MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma. PLoS ONE 2023, 18, e0277006. [Google Scholar] [CrossRef]
- Liu, Y.; Yao, J. Research progress of cystatin SN in cancer. Onco Targets Ther. 2019, 12, 3411–3419. [Google Scholar] [CrossRef]
- Chen, D.; Li, Z.; Li, Z.; Sun, Y.; Liu, Q.; Yang, J.; Song, J.; Cai, H.; Feng, Z.; Chen, Z.; et al. Transcriptome analysis of human peri-implant soft tissue and periodontal gingiva: A paired design study. Clin. Oral Investig. 2023, 27, 3937–3948. [Google Scholar] [CrossRef]
- Baron, A.C.; De Carlo, A.A.; Featherstone, J.D.B. Functional aspects of the human salivary cystatins in the oral environment. Oral Dis. 1999, 5, 234–240. [Google Scholar] [CrossRef]
- Lupi, A.; Messana, I.; Denotti, G.; Schininà, M.E.; Gambarini, G.; Fadda, M.B.; Vitali, A.; Cabras, T.; Piras, V.; Patamia, M.; et al. Identification of the human salivary cystatin complex by the coupling high-performance liquid chromatography and ion-trap mass spectrometry. Proteomics 2003, 3, 461–467. [Google Scholar] [CrossRef]
- Baron, A.C.; Gansky, S.A.; Ryder, M.I.; Featherstone, J.D.B. Cysteine protease inhibitory activity and levels of salivary cystatins in whole saliva of periodontally diseased patients. J. Periodontal. Res. 1999, 34, 437–444. [Google Scholar] [CrossRef]
- Dickinson, D.P. Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit. Rev. Oral Biol. Med. 2002, 13, 238–275. [Google Scholar] [CrossRef] [PubMed]
- Gonçalves, L.D.R.; Soares, M.R.; Nogueira, F.C.S.; Garcia, C.; Camisasca, D.R.; Domont, G.; Feitosa, A.C.R.; Pereira, D.d.A.; Zingali, R.B.; Alves, G. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J. Proteomics 2010, 73, 1334–1341. [Google Scholar] [CrossRef] [PubMed]
- Henskens, Y.M.; van der Velden, U.; Veerman, E.C.; Amerongen, A.N. Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J. Periodontal Res. 1993, 28, 43–48. [Google Scholar] [CrossRef] [PubMed]
- Aguirre, A.; Testa-Weintraub, L.A.; Banderas, J.A.; Dunford, R.; Levine, M.J. Levels of salivary cystatins in periodontally healthy and diseased older adults. Arch. Oral. Biol. 1992, 37, 355–361. [Google Scholar] [CrossRef] [PubMed]
- Aboodi, G.M.; Sima, C.; Moffa, E.B.; Crosara, K.T.B.; Xiao, Y.; Siqueira, W.L.; Glogauer, M. Salivary cytoprotective proteins in inflammation and resolution during experimental gingivitis—A pilot study. Front. Cell. Infect. Microbiol. 2016, 5, 92. [Google Scholar] [CrossRef] [PubMed]
- Henskens, Y.M.C.; van der Weijden, F.A.; van den Keijbus, P.A.M.; Veerman, E.C.I.; Timmerman, M.F.; van der Veiden, U.; Amerongen, A.V.N. Effect of periodontal treatment on the protein composition of whole and parotid saliva. J. Periodontol. 1996, 67, 205–212. [Google Scholar] [CrossRef] [PubMed]
- Sanz, M.; Herrera, D.; Kebschull, M.; Chapple, I.; Jepsen, S.; Beglundh, T.; Sculean, A.; Tonetti, M.S.; Merete Aass, A.; Aimetti, M.; et al. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline. J. Clin. Periodontol. 2020, 47, 4–60. [Google Scholar] [CrossRef] [PubMed]
- Lah, T.T.; Babnik, J.; Schiffmann, E.; Turk, V.; Skaleric, U. Cysteine proteinases and inhibitors in inflammation: Their role in periodontal disease. J. Periodontol. 1993, 64, 485–491. [Google Scholar] [PubMed]
- Skaleric, U.; Babnik, J.; Curin, V.; Lah, T.; Turk, V. Immunochemical quantitation of cysteine proteinase inhibitor cystatin C in inflamed human gingiva. Arch. Oral. Biol. 1989, 34, 301–305. [Google Scholar] [CrossRef] [PubMed]
- Matuliene, G.; Pjetursson, B.E.; Salvi, G.E.; Schmidlin, K.; Brägger, U.; Zwahlen, M.; Lang, N.P. Influence of residual pockets on progression of periodontitis and tooth loss: Results after 11 years of maintenance. J. Clin. Periodontol. 2008, 35, 685–695. [Google Scholar] [CrossRef] [PubMed]
- Vray, B.; Hartmann, S.; Hoebeke, J. Immunomodulatory properties of cystatins. Cell. Mol. Life Sci. 2002, 59, 1503–1512. [Google Scholar] [CrossRef] [PubMed]
- Kato, T.; Imatani, T.; Minaguchi, K.; Saitoh, E.; Okuda, K. Salivary cystatins induce interleukin-6 expression via cell surface molecules in human gingival fibroblasts. Mol. Immunol. 2002, 39, 423–430. [Google Scholar] [CrossRef]
- Meyle, J.; Chapple, I. Molecular aspects of the pathogenesis of periodontitis. Periodontology 2000 2015, 69, 7–17. [Google Scholar] [CrossRef]
- Tonetti, M.S.; Sanz, M. Implementation of the new classification of periodontal diseases: Decision-making algorithms for clinical practice and education. J. Clin. Periodontol. 2019, 46, 398–405. [Google Scholar] [CrossRef]
- Chapple, I.L.C.; Van der Weijden, F.; Doerfer, C.; Herrera, D.; Shapira, L.; Polak, D.; Madianos, P.; Louropoulou, A.; Machtei, E.; Donos, N.; et al. Primary prevention of periodontitis: Managing gingivitis. J. Clin. Periodontol. 2015, 42, S71–S76. [Google Scholar] [CrossRef]
- Papapanou, P.N.; Sanz, M.; Buduneli, N.; Dietrich, T.; Feres, M.; Fine, D.H.; Flemmig, T.F.; Garcia, R.; Giannobile, W.V.; Graziani, F.; et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018, 45, S162–S170. [Google Scholar] [CrossRef]
- Chapple, I.L.C.; Mealey, B.L.; Van Dyke, T.E.; Bartold, P.M.; Dommisch, H.; Eickholz, P.; Geisinger, M.L.; Genco, R.J.; Glogauer, M.; Goldstein, M.; et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018, 45, S68–S77. [Google Scholar] [CrossRef] [PubMed]
- Herrera, D.; Sanz, M.; Kebschull, M.; Jepsen, S.; Sculean, A.; Berglundh, T.; Papapanou, P.N.; Chapple, I.; Tonetti, M.S. Treatment of stage IV periodontitis: The EFP S3 level clinical practice guideline. J. Clin. Periodontol. 2022, 49, 4–71. [Google Scholar] [CrossRef] [PubMed]
- Navazesh, M. Methods for collecting saliva. Ann. N. Y. Acad. Sci. 1993, 694, 72–77. [Google Scholar] [CrossRef]
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
- Pergolizzi, B.; Carriero, V.; Abbadessa, G.; Penna, C.; Berchialla, P.; De Francia, S.; Bracco, E.; Racca, S. Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. Mol. Cell. Biochem. 2017, 434, 51–60. [Google Scholar] [CrossRef]
- Berta, G.N.; Di Scipio, F.; Yang, Z.; Oberto, A.; Abbadessa, G.; Romano, F.; Carere, M.E.; Ceccarelli, A.; Hirsch, E.; Mognetti, B. Chemical Oral Cancerogenesis Is Impaired in PI3Kγ Knockout and Kinase-Dead Mice. Cancers 2021, 13, 4211. [Google Scholar] [CrossRef] [PubMed]
Variables | Healthy Controls (H) (n = 15) | Periodontitis (P) (n = 15) | Treated Periodontitis (T) (n = 15) |
---|---|---|---|
FMPS (%) | 13.4 ± 6.2 | 79.2 ± 19.3 | 15.1 ± 10.2 |
FMBS (%) | 8.3 ± 2.7 | 68.6 ± 19.2 | 10.8 ± 9.1 |
% sites with PPD ≤ 3 mm | 99.3 ± 0.7 | 59.8 ± 17.1 | 97.3 ± 1.7 |
% sites with PPD 4–5 mm | 0.7 ± 0.6 | 23.8 ± 8.4 | 2.7 ± 1.8 |
% sites with PPD ≥ 6 mm | 0.0 ± 0.0 | 16.4 ± 12.7 | 0.0 ± 0.0 |
Number of teeth | 28.5 ± 1.2 | 24.1 ± 4.5 | 23.7 ± 3.4 |
Functional Category | N Spot | Protein Name | Protein ID | Expectation | MW |
---|---|---|---|---|---|
Hydrolases/Anti-hydrolases | 2 | α-amylase1A | P0DUB6 | 1.3 × 10−15 | 58.4 |
4 | α-amylase1A | P0DUB6 | 6.3 × 10−6 | 58.4 | |
6 | α-amylase1A | P0DUB6 | 2.0 × 10−15 | 58.4 | |
Inflammatory, antimicrobial | 1 | CST1 | P01037 | 0.63 | 16.6 |
5 | CST1 | P01037 | 0.00018 | 16.6 |
Healthy Subjects (H) | CST1 Expression | Periodontitis Subjects (P) | CST1 Expression | Treated Subjects (T) | CST1 Expression |
---|---|---|---|---|---|
H1 | + | P1 | +/− | T1 | + |
H2 | + | P2 | − | T2 | + |
H3 | + | P3 | − | T3 | + |
H4 | +/− | P4 | +/− | T4 | + |
H5 | + | P5 | − | T5 | +/− |
H6 | + | P6 | − | T6 | + |
H7 | + | P7 | + | T7 | + |
H8 | + | P8 | − | T8 | + |
H9 | + | P9 | +/− | T9 | + |
H10 | + | P10 | − | T10 | + |
H11 | +/− | P11 | − | T11 | + |
H12 | + | P12 | +/− | T12 | + |
H13 | +/− | P13 | − | T13 | + |
H14 | + | P14 | +/− | T14 | + |
H15 | + | P15 | +/− | T15 | + |
Variables | r Value |
---|---|
Age (years) | −0.066 |
FMPS (%) | −0.657 ** |
FMBS (%) | −0.628 ** |
% sites with PPD ≤ 3 mm | 0.615 ** |
% sites with PPD 4–5 mm | −0.596 * |
% sites with PPD ≥ 6 mm | −0.811 ** |
Number of teeth | 0.187 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Romano, F.; Franco, F.; Corana, M.; Abbadessa, G.; Di Scipio, F.; Pergolizzi, B.; Castrignano, C.; Aimetti, M.; Berta, G.N. Cystatin SN (CST1) as a Novel Salivary Biomarker of Periodontitis. Int. J. Mol. Sci. 2023, 24, 13834. https://doi.org/10.3390/ijms241813834
Romano F, Franco F, Corana M, Abbadessa G, Di Scipio F, Pergolizzi B, Castrignano C, Aimetti M, Berta GN. Cystatin SN (CST1) as a Novel Salivary Biomarker of Periodontitis. International Journal of Molecular Sciences. 2023; 24(18):13834. https://doi.org/10.3390/ijms241813834
Chicago/Turabian StyleRomano, Federica, Francesco Franco, Matteo Corana, Giuliana Abbadessa, Federica Di Scipio, Barbara Pergolizzi, Chiara Castrignano, Mario Aimetti, and Giovanni N. Berta. 2023. "Cystatin SN (CST1) as a Novel Salivary Biomarker of Periodontitis" International Journal of Molecular Sciences 24, no. 18: 13834. https://doi.org/10.3390/ijms241813834